Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > SP deep discount
View:
Post by Golddetector on Oct 20, 2021 2:44pm

SP deep discount

Previous financing few months back was sold at 40 cents per share and it was oversubscribed. From that time we are weeks away from Reduvo approval, finishing reborn trial enrolment and interim report for both reborn and plenitude and current sp is at 23 cents. That summarizes it. Gl longs. Btw investors were not happy about the 40 cents as it was too low.
Comment by Golddetector on Oct 21, 2021 6:31am
SP is entering stupid cheap regions imo. I added a bit yesterday. Still my big bids not filled. As I said Previous financing few months back was sold at 40 cents per share and it was oversubscribed. From that time we are weeks away from Reduvo approval, finishing reborn trial enrolment and interim report for both reborn and plenitude and current sp is at 23 cents. That summarizes it. Gl longs. Btw ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities